2 Childhood Asthma
2 Childhood Asthma
Pathophysiology:
Airways narrowing are the main visible pathology in asthma that related to 3
events:
1. Inflammation and mucosal Oedema with thickened basement membrane .
2. Bronchial Smooth Muscle Spasm and Hypertrophy.
3. Mucous plugging.
1
*if It was paroxysmal.
2- WHEEZING: especially ;
*if It was variable or intermittent.
* After exertion or at night.
**There are many presentations of asthma, The most recognizable form is the
acute episode in which the patient presents with acute shortness of breath.
Depending on the underlying degree of inflammatory damage of the airways,
the episode may have been festering with persistent cough and occasional
bouts of shortness of breath for weeks.
Failure to attend to these soft signs of "asthma in transition" may lead to an
acute case of status asthmaticus. Hence, paying attention to signs of "silent
asthma" (asthma not in an acute phase), can prevent costly and life
threatening consequences.
Asthma may appear solely as an event associated with work or exercise. Most
asthma in childhood occurs as a result of encounters with respiratory viruses. If
the asthmatic is already unstable because of a poor maintenance regimen of
the existing chronic asthma, the acute phase will begin simultaneously with the
first signs of a "cold". If the asthma is managed well, then the cough and
wheezing may occur several days after cold symptoms. Hence, early
recognition of "asthma in transition" is a major point of cooperation involving
the physician and patient.
Asthma etiology:
2
1- The most important are HERITABLE and ENVIROMENTAL factors, they
contribute to its pathogenesis.
2- Also there are at least 20 distinct chromosomal regions with linkage to
asthma and asthma related traits have been identified.
Triggering factors:
* Infections: URTI is the most common triggering factor in the 1st year of life.
most of the time children have long history of cough but suddenly they have
acute attack or acute exacerbation of symptoms.
* Pollens: common in spring season this is related to different pollens like
flowers or olives especially in Jordan, that's why sometimes prophylactic
treatment is initiated.
* House dust mites: present in every house and its hard to get rid of them coz
they found on corners, pillows, beds etc...
* Noxious agents: like air-refreshers and perfumes. Diurnal variation:
* Smoking. There is more narrowing in
* Exercise: almost in older children. asthmatics airway compared to
* Crying, Laughing: also can trigger asthma. normal person between day and
night . Explained by the diurnal
rhythm of hormones mainly
corticosteroids.
Diagnosis:
In order to diagnose asthma in young children there is certain criteria:
> 4 episodes/yr of wheezing lasting more than 1 day affecting sleep in a child
with one MAJOR or two MINOR criteria.
MAJOR CRITERIA: Risk Factors for persistent
- Parents with asthma. wheezing and predisposing to
- Physician diagnosed atopic dermatitis. asthma:
MINOR CRITERIA: - frequent wheezing in 1st year of
- Physician diagnosed allergic rhinitis. life.
- Eosinophilia (> 4%). - Maternal history of asthma or
smoking
- wheezing apart from colds. - eczema.
- High IgE levels.
Investigations:
Include- CBC, ABG with moderate to severe RD, and PULMONARY FUNCTION
TEST.
Asthmatics have tachypnea >>>>co2 washing out >>>>and finally alkalosis
which indicates good respiratory muscles function, but this is not in all patients
3
some of them as he gets exhausted and the CO2 rises he will have respiratory
acidosis then inadequate perfusion and oxygenation resulting in hypoxia and
metabolic acidosis together with respiratory acidosis.
Differential Diagnosis:
4
The first phase was described as the immediate (bronchospastic) phase and
the second phase as the late phase inflammatory response.
In the early phase of allergic inflammation, preformed mediators such as
histamine and rapidly formed mediators such as leukotrienes are released and
cause bronchospasm. Other mediators signal ; the late phase inflammatory
cells , These cells (e.g., eosinophils) recruit other cells such as epithelial cells to
participate in the resultant inflammatory damage of the airways and
subepithelial structures. These events eventually result in extensive
restructuring of the normal histology of the airways. This damage is not
restored by beta-2 bronchodilators.
An important immunologic occurrence is the activation of the Th2 helper cell,
which is pivotal in the progression of the allergic immunologic process. The
other helper designated Th1 cell does not enhance the allergic inflammatory
process.
acute exacerbations are treated with quick relief (or rescue) medications,
which is most commonly prn albuterol and optional short bursts of systemic
corticosteroids.
Step 2 (mild persistent): Day symptoms greater than two times per week, but
less than once per day or night symptoms greater than nights per month.
Chronic peak flow is still 80% of expected or higher.
*This step recommends a low dose inhaled corticosteroid. Alternatively,
a cromolyn medication or a leukotriene receptor antagonist may be used.
Theophylline is another option, but only in children older than 5 years.
………………………………….
Here , wht the Doctor talked about management in the lecture :
** Oxygen
Any patients with acute attack we give him O2 by mask 8-10 L/min to keep the
saturation above 95%.
It has side effects can lead to Retinopathy, Prematurity, Bronchopulmonary
dysplasia.
That’s why in NICU O2 is monitored and not allowed to increase >98%.
6
Don’t forget that prolonged 100% O2 can cause lung tissue damage.
** Nebulizer Salbutamol
it is a beta-2 agonist , given after O2 an acute attack at least 8 L/min given by
mask.
The large volume and high gas flow through the nebulizer produce a small
aerosol particle size, maximizing deposition of the drug in small airways.
Side effects: hypokalemia, hyperglycemia, tachycardia, palpitation and tremor.
** Corticosteroids
(prednisolone – O.
methylprednisolone - O, IV.
dexamethasone - O, IV).
- most important drug in asthma, it takes long time to work 4-6 hrs.
– reduce the severity of acute severe asthma.
– reduce the inflammation in bronchial mucous.
– potentiate the relaxation of bronchial smooth muscle by beta-2 agonists.
– reduce mucous production.
– decrease recruitment and activation of inflammatory cells.
– decrease microvascular permeability.
– Up regulates B2 receptors.
**Ipratropium Bromide
- anti-cholinergic bronchodilator with no systemic atropine like effects and no
inhibition of mucociliary clearance.
– has a good synergy with beta-2 agonist and can be mixed with salbutamol in
nebulizer.
7
Also if there is no response we give:
**Aminophylline
as dr said the use of this drug is controversial, because the therapeutic levels
are narrow as it causes many side effects like convulsions. So plasma levels
should be monitored.
**IV Salbutamol
unfortunately this drug not found in Jordan.
**Magnesium Sulfate
it is bronchodilator with unclear MOA but maybe due to:
1- inhibition of Ca++ mediated smooth muscle contraction.
2- Direct inhibition of smooth muscle contraction.
Can be given IV or Nebulized.
**Ketamine
- it is sedative and analgesic drug can be used in asthma.
– has sympathomimetic action.
-Side effects : arrhythmia, laryngospasm, increased secretions.
Contraindicated in pts with neurological problems and hyperkalemia .
8
- Heliox: O2 and Helium.
- ECMO: extracorporeal membrane oxygenation (artificial lung).only if the
cause is reversible like infection.
- CPAP.
## CONTROLLERS MEDICATIONS:
1- inhaled corticosteroids. ***before discharge we should
2- leukotriene modifiers. advise the pt to avoid all the
triggering factors, educate
3- Long acting inhaled beta-2 agonists.
patients and parents and
4- theophylline: long acting{slow release}. planning for management at
5- cromones: useless in children. home.
6- long acting oral beta-2 agonist.
7- Systemic glucocorticosteroids.
Prevalence:
9
- There is familial tendency, if one of the parents has asthma it will increase the
incidence in the siblings. There is no definite mode of inheritance it is a
multifactorial.
ASTHMA EDUCATION:
Self managed education associated with:
- Improvement in air flow.
- Improvement in self efficacy scales.
- Reduction in school absence.
- Reduction in emergency room visits.
Now , I will give you 2 cases from Dr Samah tables and ask about the severity,
control and treatment of each one.
**I will put the tables here but they aren't clear, so you can find the tables on the
website :
- The First Table talks about the classification of the severity of asthma until the
age of 11 . (There are other tables for the ages ≥12 years .)
- The second table is talking about the assessment of control of asthma .
- The third table talks about the steps of treatment .
11
**Table 1
**table 2
11
**table 3 :
CASE 1
A 6 year-old male presented to our clinic :
determined by both :
1. Impairment :
- Symptoms.
- Night time awakenings .
12
- Short-acting β2-agonists used for system control .
- Interference with normal activity .
- Lung function
2. Risk .
** if we are confused whether it’s mild or moderate for example , you take the
higher level of severity always .
“It’s not required from you , when you take a history of asthma that you
determine the level of severity . but you should know the difference between the
intermittent and the persistent ( memorize the intermittent and anything else will be
persistent ) and you should include the criteria of severity in your history”.
*Second , What medications would you use for long term management ?
I prefer using the medium dose ICS because we try to avoid using LABA until we
need it as we try to minimize the number of medications and decrease the incidence of
poor control . There are practical and scientific points in determining what we use .
- Scientific point : they prefer option 1 to minimize the S.E of ICS that can
happen with medium to high dose .
- Practical point : they prefer option 2 which is starting with higher dose because
we hate for the kid to experience poor control and experience the symptoms coming back.
** it’s not required to know what medications is given in each step but you
should know that in any persistent level of asthma , we should start with a controller
medicine ( the best is ICS) .
13
What is the level of Control ?
Before stepping up the treatment we should make sure that the patient is 1 using
the medication appropriately ,2 is compliant , and 3 the environment is free of triggering
factors .
“”” Why the doctor is giving us this ?? because 6th year students were asked in
OSCI exam : ( patient → symptoms daily , used β2-agonist several times/day , he wakes
up every night, he goes to the ER every 2 weeks , Exacerbation 4 times/year ) , is the
asthma is controlled or not ?
They are not asked about the level of control , it’s just controlled or not but they
didn’t know what that means so “ it’s a shame “ ..
CASE 2
A 5 year-old female presented with :
14